The certification keeps Aurora positioned for international medical cannabis sales but provides no immediate catalyst. Monitor future quarterly filings for revenue contributions from the Safari facility and EU market developments.
Price Chart
Executive Summary
Aurora Cannabis subsidiary Safari Flower Company received EU-GMP certification for its 59,000 sq ft Niagara facility, enabling continued supply to regulated medical cannabis markets in Germany, Poland, and the UK. The certification is a positive operational milestone but does not include any financial figures or guidance changes.
Key Facts
- Safari Flower Company, a wholly owned subsidiary of Aurora Cannabis, received EU-GMP certification for its Niagara facility.
- The certification is valid for a three-year term.
- The facility is 59,000 square feet and supports international medical cannabis exports to Germany, Poland, and the UK.
- Aurora acquired Safari Flower Company in April 2026 to add EU-GMP capacity.
- No financial data, revenue, earnings, or guidance were disclosed in the filing.
Financial Impact
No specific financial impact provided; certification enables potential revenue from international markets but no dollar amounts disclosed.
Risk Factors
- EU-GMP certification does not guarantee revenue; market demand and competition remain factors.
- Forward-looking statements about international market growth are subject to regulatory and economic risks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001279569-26-000696 |
| Document: aurora_6k.htm | 0001279569-26-000696 |
| Document: 0001279569-26-000696-index-headers.html | 0001279569-26-000696 |
| Document: 0001279569-26-000696-index.html | 0001279569-26-000696 |
| Document: 0001279569-26-000696.txt | 0001279569-26-000696 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $3.87 | awaiting T+5 | — | $3.86 (−0.26%) |
Oct 14, 2026 11d ago | 6-K | $4.10 $3.97 | ▼ −3.17% | ▼ −2.16% | $3.86 (−5.85%) |
Oct 8, 2026 18d ago | 6-K | $4.43 $4.10 | ▼ −7.45% | ▼ −7.17% | $3.86 (−12.87%) |
Oct 6, 2026 19d ago | 6-K | $4.46 $4.17 | ▼ −6.50% | ▼ −5.52% | $3.86 (−13.45%) |
Oct 5, 2026 20d ago | 6-K | $4.59 $4.29 | ▼ −6.54% | ▼ −6.40% | $3.86 (−15.90%) |
Sep 16, 2026 5w ago | 6-K | $3.83 $4.22 | ▲ +10.18% | ▲ +7.62% | $3.86 (+0.78%) |
Sep 14, 2026 5w ago | 6-K | $3.81 $4.03 | ▲ +5.77% | ▲ +5.67% | $3.86 (+1.31%) |
Sep 9, 2026 6w ago | 6-K | $3.88 $3.83 | ▼ −1.29% | ▼ −0.63% | $3.86 (−0.52%) |
Sep 2, 2026 7w ago | 6-K | $4.03 $3.73 | ▼ −7.44% | ▼ −6.49% | $3.86 (−4.22%) |
Aug 24, 2026 9w ago | 6-K | $3.94 $4.05 | ▲ +2.79% | ▲ +2.32% | $3.86 (−2.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers